PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IHE vs. VYM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


IHEVYM
YTD Return6.78%8.37%
1Y Return14.77%19.83%
3Y Return (Ann)7.34%7.11%
5Y Return (Ann)10.97%10.34%
10Y Return (Ann)9.13%9.89%
Sharpe Ratio1.061.92
Daily Std Dev13.52%10.51%
Max Drawdown-35.30%-56.98%
Current Drawdown-5.12%-0.57%

Correlation

-0.50.00.51.00.7

The correlation between IHE and VYM is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

IHE vs. VYM - Performance Comparison

In the year-to-date period, IHE achieves a 6.78% return, which is significantly lower than VYM's 8.37% return. Over the past 10 years, IHE has underperformed VYM with an annualized return of 9.13%, while VYM has yielded a comparatively higher 9.89% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


300.00%400.00%500.00%600.00%700.00%December2024FebruaryMarchAprilMay
688.78%
309.09%
IHE
VYM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


iShares U.S. Pharmaceuticals ETF

Vanguard High Dividend Yield ETF

IHE vs. VYM - Expense Ratio Comparison

IHE has a 0.42% expense ratio, which is higher than VYM's 0.06% expense ratio.


IHE
iShares U.S. Pharmaceuticals ETF
Expense ratio chart for IHE: current value at 0.42% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.42%
Expense ratio chart for VYM: current value at 0.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.06%

Risk-Adjusted Performance

IHE vs. VYM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Vanguard High Dividend Yield ETF (VYM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IHE
Sharpe ratio
The chart of Sharpe ratio for IHE, currently valued at 1.06, compared to the broader market0.002.004.001.06
Sortino ratio
The chart of Sortino ratio for IHE, currently valued at 1.63, compared to the broader market-2.000.002.004.006.008.0010.001.63
Omega ratio
The chart of Omega ratio for IHE, currently valued at 1.19, compared to the broader market0.501.001.502.002.501.19
Calmar ratio
The chart of Calmar ratio for IHE, currently valued at 1.23, compared to the broader market0.005.0010.0015.001.23
Martin ratio
The chart of Martin ratio for IHE, currently valued at 3.18, compared to the broader market0.0020.0040.0060.0080.003.18
VYM
Sharpe ratio
The chart of Sharpe ratio for VYM, currently valued at 1.92, compared to the broader market0.002.004.001.92
Sortino ratio
The chart of Sortino ratio for VYM, currently valued at 2.78, compared to the broader market-2.000.002.004.006.008.0010.002.78
Omega ratio
The chart of Omega ratio for VYM, currently valued at 1.33, compared to the broader market0.501.001.502.002.501.33
Calmar ratio
The chart of Calmar ratio for VYM, currently valued at 2.03, compared to the broader market0.005.0010.0015.002.03
Martin ratio
The chart of Martin ratio for VYM, currently valued at 6.36, compared to the broader market0.0020.0040.0060.0080.006.36

IHE vs. VYM - Sharpe Ratio Comparison

The current IHE Sharpe Ratio is 1.06, which is lower than the VYM Sharpe Ratio of 1.92. The chart below compares the 12-month rolling Sharpe Ratio of IHE and VYM.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00December2024FebruaryMarchAprilMay
1.06
1.92
IHE
VYM

Dividends

IHE vs. VYM - Dividend Comparison

IHE's dividend yield for the trailing twelve months is around 3.30%, more than VYM's 2.84% yield.


TTM20232022202120202019201820172016201520142013
IHE
iShares U.S. Pharmaceuticals ETF
3.30%4.16%6.02%4.48%3.57%4.19%3.76%4.08%2.75%5.78%3.60%3.19%
VYM
Vanguard High Dividend Yield ETF
2.84%3.12%3.01%2.76%3.18%3.03%3.40%2.80%2.91%3.22%2.78%2.81%

Drawdowns

IHE vs. VYM - Drawdown Comparison

The maximum IHE drawdown since its inception was -35.30%, smaller than the maximum VYM drawdown of -56.98%. Use the drawdown chart below to compare losses from any high point for IHE and VYM. For additional features, visit the drawdowns tool.


-10.00%-8.00%-6.00%-4.00%-2.00%0.00%December2024FebruaryMarchAprilMay
-5.12%
-0.57%
IHE
VYM

Volatility

IHE vs. VYM - Volatility Comparison

iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 3.21% compared to Vanguard High Dividend Yield ETF (VYM) at 2.42%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than VYM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%December2024FebruaryMarchAprilMay
3.21%
2.42%
IHE
VYM